SITC Archive Library

SITC 2017 Annual Meeting: Concurrent Session 104: Clinical Trials: New Agents 

11-21-2017 11:22

The Society for Immunotherapy of Cancer (SITC) hosted the "Concurrent Session 104: Clinical Trials: New Agents" during the SITC 2017 Annual Meeting on November 10, 2017. Available here are the presentation slides and video from the session.

Program Organizers

  • Chair: Mario Sznol, MD – Yale School of Medicine
  • Charlie Garnett Benson, PhD – Georgia State University
  • Elizabeth A. Repasky, PhD – Roswell Park Cancer Institute

Program Summary

The Society for Immunotherapy of Cancer's (SITC) 32nd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.

Intended Audience

The audience included U.S. and international researchers, regulators and healthcare professionals involved in cancer research and clinical care. This included, but was not limited to basic, translational and clinical researchers; postdoctoral fellows; oncologists; registered nurses; nurse practitioners; pharmacists; payers; and other allied health professionals.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#ClinicalTrials#PresentationSlides#Video#AnnualMeeting#SITC#AlliedHealth
#Clinician#Industry#Researcher#2017#BreastCancers#ColorectalCancer
#GenitourinaryCancers#HeadandNeckCancers#Lymphoma#LungCancers
#Melanoma#NonSmallCellLungCancer#Cytokines#ImmuneCheckpointInhibitors
#TherapeuticAntibodies#AdverseEvents

Statistics
0 Favorited
301 Views
10 Files
0 Shares
466 Downloads

 Video
Attachment(s)
pdf file
"First-in-Human Study With Intratumoral Administration of...   3.74 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Peter Ellmark, PhD – Alligator Bioscience; Date: November 10, 2017
mp4 file
"First-in-Human Study With Intratumoral Administration of...   171.64 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Peter Ellmark, PhD – Alligator Bioscience; Date: November 10, 2017
pdf file
"Monotherapy Dose Escalation Clinical and Translational D...   6.11 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: David Hong, MD – University of Texas MD Anderson Cancer Center; Date: November 10, 2017
mp4 file
"Monotherapy Dose Escalation Clinical and Translational D...   149.74 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: David Hong, MD – University of Texas MD Anderson Cancer Center; Date: November 10, 2017
pdf file
"Phase 1 Trial of CA-170, a First-in-Class, Orally Availa...   3.13 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Yung Jue Bang, PhD, MD – Seoul National University Hospital; Date: November 10, 2017
mp4 file
"Phase 1 Trial of CA-170, a First-in-Class, Orally Availa...   112.85 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Yung Jue Bang, PhD, MD – Seoul National University Hospital; Date: November 10, 2017
pdf file
"Phase I trial of IL-15 Superagonist ALT-803 (IL-15N72D:I...   1.10 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Kim Margolin, MD, FACP – City of Hope; Date: November 10, 2017
mp4 file
"Phase I trial of IL-15 Superagonist ALT-803 (IL-15N72D:I...   212.52 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: Kim Margolin, MD, FACP – City of Hope; Date: November 10, 2017
pdf file
"Initial Results from Phase 1 Trial of M7824 (MSB0011359C...   1.11 MB   1 version
Uploaded - 11-21-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: James L. Gulley, MD, PhD, FACP – National Cancer Institute; Date: November 10, 2017
mp4 file
"Initial Results from Phase 1 Trial of M7824 (MSB0011359C...   203.90 MB   1 version
Uploaded - 12-06-2017
Meeting: SITC 32 Annual Meeting; Concurrent Session 104: Clinical Trials: New Agents; Presenter: James L. Gulley, MD, PhD, FACP – National Cancer Institute; Date: November 10, 2017